目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources of secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key primary insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 DEMAND-SIDE APPROACH
2.2.4 VOLUME DATA ANALYSIS
2.2.5 PROCEDURE DATA ANALYSIS
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW
4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER AND COUNTRY, 2023
4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX
4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases
5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer
5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations
5.2.1.4 Technological advancements in endoscopic ultrasound devices
5.2.2 RESTRAINTS
5.2.2.1 High costs of endoscopic ultrasound procedures
5.2.2.2 Complications and limitations of endoscopic ultrasound
5.2.3 OPPORTUNITIES
5.2.3.1 High market growth potential in emerging economies
5.2.3.2 Increasing preference for minimally invasive surgeries
5.2.4 CHALLENGES
5.2.4.1 Increasing number of product recalls
5.3 INDUSTRY TRENDS
5.3.1 ULTRASOUND CAPSULE ENDOSCOPY
5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 Contrast-enhanced endoscopic ultrasound
5.6.1.2 Lumen-apposing metal stents
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Elastography
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 KEY STAKEHOLDERS & BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.8.2 KEY BUYING CRITERIA
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY FRAMEWORK
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.2.1 Germany
5.9.1.2.2 France
5.9.1.2.3 UK
5.9.1.2.4 Italy
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021-2023
5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021-2023
5.11 ECOSYSTEM ANALYSIS
5.11.1 ROLE IN ECOSYSTEM
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 TRADE ANALYSIS
5.13.1 IMPORT DATA FOR HS CODE 901890
5.13.2 EXPORT DATA FOR HS CODE 901890
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 UNMET NEEDS/END-USER EXPECTATIONS
5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET
5.17 CASE STUDY ANALYSIS
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.19 ADJACENT MARKETS
5.20 INVESTMENT & FUNDING SCENARIO

6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ENDOSCOPES
6.2.1 RADIAL ENDOSCOPES
6.2.1.1 High image quality, improved penetration depth, and excellent maneuverability to propel segment growth
6.2.2 LINEAR ENDOSCOPES
6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth
6.3 ULTRASOUND PROCESSORS
6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING
6.4 ULTRASOUND PROBES
6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH
6.5 ULTRASOUND NEEDLES
6.5.1 FINE NEEDLE ASPIRATION
6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth
6.5.2 FINE NEEDLE BIOPSIES
6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth
6.5.3 OTHER ULTRASOUND NEEDLES
6.6 ACCESSORIES
6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET

7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE
7.1 INTRODUCTION
7.2 DIAGNOSTICS
7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH
7.3 THERAPEUTICS
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH

8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 ONCOLOGY
8.2.1 UPPER GASTROINTESTINAL ONCOLOGY
8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment
8.2.2 LOWER GASTROINTESTINAL ONCOLOGY
8.2.2.1 High prevalence of colorectal cancer to support segment growth
8.3 GASTROINTESTINAL DISORDERS
8.3.1 PANCREATIC DISORDERS
8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth
8.3.2 OTHER GASTROINTESTINAL DISORDERS
8.4 OTHER APPLICATIONS

9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH
9.3 AMBULATORY SURGERY CENTERS
9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH
9.4 OTHER END USERS

10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period
10.2.3 CANADA
10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth
10.3.3 UK
10.3.3.1 High government healthcare funding to support market growth
10.3.4 FRANCE
10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth
10.3.5 ITALY
10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth
10.3.6 SPAIN
10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth
10.4.3 CHINA
10.4.3.1 Large patient pool and high obesity rates to drive market
10.4.4 INDIA
10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth
10.4.5 SOUTH KOREA
10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth
10.4.6 AUSTRALIA
10.4.6.1 Increased patient volume and favorable government initiatives to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth
10.5.3 MEXICO
10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth
10.6.3 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET
11.3 REVENUE ANALYSIS, 2019-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Type footprint
11.5.5.5 Application footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.8 BRAND/PRODUCT COMPARISON
11.9 R&D ASSESSMENT OF KEY PLAYERS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & APPROVALS
11.10.2 EXPANSIONS
11.10.3 DEALS
11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 OLYMPUS CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 MEDTRONIC
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 FUJIFILM HOLDINGS CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches & approvals
12.1.3.3.2 Deals
12.1.3.3.3 Other developments
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 BOSTON SCIENTIFIC CORPORATION
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product approvals
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 PENTAX MEDICAL
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches & approvals
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 STERIS
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.6.3.2 Expansions
12.1.7 CONMED CORPORATIONn
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product approvals
12.1.9 CANON MEDICAL SYSTEMS CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 COOK
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.10.3.3 Expansions
12.2 OTHER PLAYERS
12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
12.2.2 SONOSCAPE MEDICAL CORP.
12.2.3 ENDOSOUND, INC.
12.2.4 LIMACA-MEDICAL
12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD.
12.2.6 KAIGEN PHARMA CO., LTD.
12.2.7 PIOLAX MEDICAL DEVICES, INC.
12.2.8 MICRO-TECH ENDOSCOPY
12.2.9 SHAILI ENDOSCOPY
12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
12.2.11 ENDO-FLEX GMBH
12.2.12 ACE MEDICAL DEVICES PVT. LTD.
12.2.13 MEDI-GLOBE GMBH
12.2.14 MEDORAH MEDITEK PVT. LTD.
12.2.15 INNERMEDICAL CO., LTD.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS